Sars-COV-2/flu PCR
Ended Awarded Last action
- Contract number
- W81K0024F0069
- Awardee
-
Cepheid UEI W6HQTMWB9Q28
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $880,533
Award facts
- Opportunity
-
- Real Time Polymer Chain Reaction Analyzers Pre-Solicitation · W81K0023R0012 · Posted Mar 29, 2023
- Contract value 100% obligated
- $880,532.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- 2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$209,590 | |
| Change Order | -$283,560 | |
| Funding Only Action | $1,373,683 | |
| Terminate for Convenience | $0 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a delivery order to Cepheid Inc. for SARS-CoV-2/Flu PCR testing supplies with a ceiling value of $880,532.90 under a firm fixed-price contract type. The delivery order, awarded on October 1, 2024, is scheduled for completion by September 30, 2025, and will support molecular diagnostic testing operations at Fort Sam Houston, Texas. This award reflects the Defense Health Agency's continued reliance on Cepheid's GeneXpert diagnostic platform and associated reagents to maintain rapid infectious disease detection capabilities across military medical facilities. No small business set-aside was utilized in this procurement.
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, has established itself as a primary federal supplier of infectious disease testing solutions across multiple healthcare agencies. The company's extensive federal contracting history includes substantial indefinite delivery contracts with the Department of Veterans Affairs, including a $32.8 million contract with VISN 6 extending through 2030, and prior awards from the Indian Health Service, Defense Logistics Agency, and U.S. Coast Guard. Cepheid's core competencies encompass PCR test kits, diagnostic reagents and assays, equipment maintenance services, and cost-per-test arrangements for conditions including COVID-19, influenza, and other respiratory pathogens, positioning the company as a critical supplier to the federal healthcare procurement market.
Quick answers
Who was awarded contract W81K0024F0069?
W81K0024F0069 was awarded to Cepheid by Medical Command (Department of the Army) on October 1, 2024.
How much is contract W81K0024F0069 worth?
The government has obligated $880,533 on W81K0024F0069.
Which agency awarded contract W81K0024F0069?
Medical Command (Department of the Army) awarded W81K0024F0069, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0024F0069 an order under another contract?
Yes. W81K0024F0069 is a delivery order under W81K0023D0005, an indefinite delivery contract.
Was contract W81K0024F0069 competed?
The extent of competition for W81K0024F0069 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award